Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1167

1.

Cardiac risk factors: new cholesterol and blood pressure management guidelines.

Anthony D, George P, Eaton CB; 2013 American College of Cardiology/American Heart Association; Eighth Joint National Committee.

FP Essent. 2014 Jun;421:28-43.

PMID:
24936717
[PubMed - indexed for MEDLINE]
3.

Effects of fenofibric acid on carotid intima-media thickness in patients with mixed dyslipidemia on atorvastatin therapy: randomized, placebo-controlled study (FIRST).

Davidson MH, Rosenson RS, Maki KC, Nicholls SJ, Ballantyne CM, Mazzone T, Carlson DM, Williams LA, Kelly MT, Camp HS, Lele A, Stolzenbach JC.

Arterioscler Thromb Vasc Biol. 2014 Jun;34(6):1298-306. doi: 10.1161/ATVBAHA.113.302926. Epub 2014 Apr 17.

PMID:
24743431
[PubMed - indexed for MEDLINE]
4.

Gender differences in achieving optimal lipid goals in patients with coronary artery disease.

Victor BM, Teal V, Ahedor L, Karalis DG.

Am J Cardiol. 2014 May 15;113(10):1611-5. doi: 10.1016/j.amjcard.2014.02.018. Epub 2014 Mar 1.

PMID:
24698458
[PubMed - indexed for MEDLINE]
5.

Effects of niacin combination therapy with statin or bile acid resin on lipoproteins and cardiovascular disease.

Zambon A, Zhao XQ, Brown BG, Brunzell JD.

Am J Cardiol. 2014 May 1;113(9):1494-8. doi: 10.1016/j.amjcard.2014.01.426. Epub 2014 Feb 11.

PMID:
24641964
[PubMed - indexed for MEDLINE]
6.

Effectiveness of combination therapy with statin and another lipid-modifying agent compared with intensified statin monotherapy: a systematic review.

Gudzune KA, Monroe AK, Sharma R, Ranasinghe PD, Chelladurai Y, Robinson KA.

Ann Intern Med. 2014 Apr 1;160(7):468-76. doi: 10.7326/M13-2526. Review.

PMID:
24514899
[PubMed - indexed for MEDLINE]
7.

Should we forget about low-density lipoprotein cholesterol?

Civeira F, Ascaso J, Masana L.

J Am Coll Cardiol. 2014 Apr 1;63(12):1228-9. doi: 10.1016/j.jacc.2013.11.054. Epub 2014 Feb 5. No abstract available.

PMID:
24509272
[PubMed - indexed for MEDLINE]
8.

Treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: synopsis of the 2013 American College of Cardiology/American Heart Association cholesterol guideline.

Stone NJ, Robinson JG, Lichtenstein AH, Goff DC Jr, Lloyd-Jones DM, Smith SC Jr, Blum C, Schwartz JS; 2013 ACC/AHA Cholesterol Guideline Panel.

Ann Intern Med. 2014 Mar 4;160(5):339-43. doi: 10.7326/M14-0126.

PMID:
24474185
[PubMed - indexed for MEDLINE]
9.

Post-marketing study of clinical experience of atorvastatin 80 mg vs 40 mg in Indian patients with acute coronary syndrome- a randomized, multi-centre study (CURE-ACS).

Kaul U, Varma J, Kahali D, Hiremath MS, Dani S, Dalal J, Ramchandran P, Rane R, Barkate H, Jindal C.

J Assoc Physicians India. 2013 Feb;61(2):97-101.

PMID:
24471247
[PubMed - indexed for MEDLINE]
10.

The relationship between low-density lipoprotein cholesterol levels and the incidence of cardiovascular disease in high-risk patients treated with pravastatin: main results of the APPROACH-J study.

Daida H, Teramoto T, Kitagawa Y, Matsushita Y, Sugihara M.

Int Heart J. 2014;55(1):39-47. Epub 2014 Jan 27. Erratum in: Int Heart J. 2014;55(2):184.

PMID:
24463915
[PubMed - indexed for MEDLINE]
Free Article
11.

Peripheral microvascular dysfunction predicts residual risk in coronary artery disease patients on statin therapy.

Matsue Y, Yoshida K, Nagahori W, Ohno M, Suzuki M, Matsumura A, Hashimoto Y, Yoshida M.

Atherosclerosis. 2014 Jan;232(1):186-90. doi: 10.1016/j.atherosclerosis.2013.11.038. Epub 2013 Nov 20.

PMID:
24401235
[PubMed - indexed for MEDLINE]
12.

Effects of rosuvastatin vs. simvastatin/ezetimibe on arterial wall stiffness in patients with coronary artery disease.

Liu B, Che W, Yan H, Zhu W, Wang H.

Intern Med. 2013;52(24):2715-9.

PMID:
24334573
[PubMed - indexed for MEDLINE]
Free Article
13.

A pragmatic view of the new cholesterol treatment guidelines.

Keaney JF Jr, Curfman GD, Jarcho JA.

N Engl J Med. 2014 Jan 16;370(3):275-8. doi: 10.1056/NEJMms1314569. Epub 2013 Nov 27. No abstract available.

PMID:
24283199
[PubMed - indexed for MEDLINE]
14.

Validating the benefits of lipid modifying therapies upon atherosclerotic plaque by computed tomography angiography: should we trust our eyes? Commentary on the study of Zeb et al.

Rached FH, Santos RD.

Atherosclerosis. 2013 Dec;231(2):189-90. doi: 10.1016/j.atherosclerosis.2013.09.015. Epub 2013 Oct 1. No abstract available.

PMID:
24267224
[PubMed - indexed for MEDLINE]
15.

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW; American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2889-934. doi: 10.1016/j.jacc.2013.11.002. Epub 2013 Nov 12. No abstract available. Erratum in: J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):3024-3025.

PMID:
24239923
[PubMed - indexed for MEDLINE]
Free Article
16.

Echolucency of carotid plaque is useful for assessment of residual cardiovascular risk in patients with chronic coronary artery disease who achieve LDL-C goals on statin therapy.

Uematsu M, Nakamura T, Sugamata W, Kitta Y, Fujioka D, Saito Y, Kawabata K, Obata JE, Watanabe Y, Watanabe K, Kugiyama K.

Circ J. 2014;78(1):151-8. Epub 2013 Nov 12.

PMID:
24225306
[PubMed - indexed for MEDLINE]
Free Article
17.

First-line treatment patterns and lipid target levels attainment in very high cardiovascular risk outpatients.

Xanthopoulou I, Davlouros P, Siahos S, Perperis A, Zaharioglou E, Alexopoulos D.

Lipids Health Dis. 2013 Nov 9;12:170. doi: 10.1186/1476-511X-12-170.

PMID:
24209409
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Lack of goal attainment regarding the low-density lipoprotein cholesterol level in the management of type 2 diabetes mellitus.

Hosokawa M, Hamasaki A, Nagashima K, Harashima S, Toyoda K, Fujita Y, Harada N, Nakahigashi Y, Fujimoto S, Inagaki N.

Intern Med. 2013;52(21):2409-15.

PMID:
24190144
[PubMed - indexed for MEDLINE]
Free Article
19.
20.

Lipoprotein(a) for risk assessment in patients with established coronary artery disease.

O'Donoghue ML, Morrow DA, Tsimikas S, Sloan S, Ren AF, Hoffman EB, Desai NR, Solomon SD, Domanski M, Arai K, Chiuve SE, Cannon CP, Sacks FM, Sabatine MS.

J Am Coll Cardiol. 2014 Feb 18;63(6):520-7. doi: 10.1016/j.jacc.2013.09.042. Epub 2013 Oct 23.

PMID:
24161323
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk